Diagnóstico y tratamiento de la Encefalopatía Hepática

dc.contributor.authorJaime Castellón Jimenez
dc.contributor.authorVanesa Castro Kenia
dc.contributor.authorJuan Carlos Sánchez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T17:06:07Z
dc.date.available2026-03-22T17:06:07Z
dc.date.issued2013
dc.description.abstractHepatic encephalopathy is a complex neuropsychiatric syndrome seen with great frequency in patients with chronic liver cirrhosis. The main aspect in its pathophysiology is the access from portal blood to the systemic circulation. This causes the brain's exposure to high concentrations of toxic substances (especially ammonia) which cause changes in astrocytes and defects in neurotransmission. The diagnosis is established by demonstrating compatible neurological, signs of liver disease and having ruled out other neurological diseases that can cause similar manifestations. The management of hepatic encephalopathy is based on maintaining and minimizing medical complications of patients with liver cirrhosis and correcting precipitating factors. Currently, they are researching a series of molecules that affect the metabolism of ammonia and could play a role in therapy such as lactulose and L-Ornithine and L-aspartate INTRODUCCION
dc.identifier.urihttps://dialnet.unirioja.es/descarga/articulo/4477744.pdf
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/62176
dc.language.isoes
dc.relation.ispartofRevista Científica Ciencia Médica
dc.sourceUniversity of San Simón
dc.subjectHepatic encephalopathy
dc.subjectCirrhosis
dc.subjectMedicine
dc.subjectEncephalopathy
dc.subjectPathophysiology
dc.subjectLiver disease
dc.subjectChronic liver disease
dc.subjectGastroenterology
dc.subjectDisease
dc.subjectLactulose
dc.titleDiagnóstico y tratamiento de la Encefalopatía Hepática
dc.typearticle

Files